During the 12 months ending in September 2024, the company has reduced antibiotic and antiparasitic use.
Salmones Camanchaca
Salmones Camanchaca has reported that during the third quarter of 2024, its accumulated revenue grew by 10%, reaching USD 284 million, primarily driven by a 22% increase in sales volume.
Despite the increase in these figures, weak demand has led to a lower price for the product. As a result, Atlantic salmon harvests were 33,972 metric tons WFE (Whole Fish Equivalent), 4% lower than in the first nine months of the previous year, and sales reached 32.2 thousand metric tons WFE, with an 8% lower price.
Thanks to weight recovery, good sanitary conditions at harvested sites, and a downward trend in feed costs, the quarterly cost of harvested Atlantic salmon has decreased, 13% lower than in the third quarter of 2023.
During the 12 months ending in September 2024, the company reduced antibiotic use by 40% and antiparasitic use by 9% compared to the same period in 2022.
Regarding these data Vice Chairman Ricardo García said: "Although prices have not recovered and demand for seafood remains weak, we have managed, through a series of measures, to reduce production costs, especially at sea, associated with an improvement in the sanitary and biological conditions of the sites, allowing for higher harvest weights and a reduction in other operational costs, along with a drop in feed costs."
"For 2025, we estimate increasing our Atlantic salmon harvests to a range of 52 to 54 thousand MT WFE and maintaining between 3 and 4 thousand MT WFE of Coho, continuing our efforts to lower costs and adapt to customer and market needs," he concluded.
